The peptide-binding strategy of the MHC class II I-A molecules (original) (raw)

The I-Ag7 MHC Class II Molecule Linked to Murine Diabetes Is a Promiscuous Peptide Binder

Journal of Immunology, 2000

That Are Peptide Dependent Exists in Alternate Conformations g7 The MHC Class II Molecule IA

Naturally processed peptides from HLA-DQ7 (α1*0501-β1*0301): influence of both α and β chain polymorphism in the HLA-DQ peptide binding specificity

Dominique Charron

European Journal of Immunology, 1998

View PDFchevron_right

The MHC Class II Molecule I-Ag7 Exists in Alternate Conformations That Are Peptide Dependent

Andrea Sant

The Journal of Immunology, 2000

View PDFchevron_right

The lack of consensus for I-Ag7-peptide binding motifs: Is there a requirement for anchor amino acid side chains?

Osami Kanagawa

Proceedings of the National Academy of Sciences, 1999

View PDFchevron_right

Conformation of MHC class II I-Ag7 is sensitive to the P9 anchor amino acid in bound peptide

Lynne Arneson

International Immunology, 2007

View PDFchevron_right

A Peptide-binding Motif for IA g7 , the Class II Major Histocompatibility Complex (MHC) Molecule of NOD and Biozzi AB/H Mice

Vladimir Brusic

View PDFchevron_right

Conformation of MHC class II I-Ag7 is sensitive to the

Lynne Arneson

2015

View PDFchevron_right

Structural requirements for the interaction between class II MHC molecules and peptide antigens

Luciano Adorini

Immunologic Research, 1990

View PDFchevron_right

Peptide motif of the class I molecule HLA-B*1503

Ken Jackson, William Hildebrand

Immunogenetics, 1999

View PDFchevron_right

Differential binding of peptides substituted at putative C-terminal anchor residues to HLA-DQ8 and DQ9 differing only at β57

Sho Matsushita

Human Immunology, 1997

View PDFchevron_right

Characterization of peptides bound to extra- and intracellular HLA-DR1 molecules

Thomas M Halder

Human Immunology, 1993

View PDFchevron_right

A Peptide Binding Motif for I-Eg7, the MHC Class II Molecule That Protects Eα-Transgenic Nonobese Diabetic Mice from Autoimmune Diabetes

Luciano Adorini

The Journal of Immunology, 1999

View PDFchevron_right

Monoclonal Antibodies Specific for the Empty Conformation of HLA-DR1 Reveal Aspects of the Conformational Change Associated with Peptide Binding

Laura Santambrogio, Lawrence Stern

Journal of Biological Chemistry, 2004

View PDFchevron_right

A continuous central motif of invariant chain peptides, CLIP, is essential for binding to various I-A MHC class II molecules

Peter Milburn

International Immunology, 1997

View PDFchevron_right

Amino Acid Residues Essential for Biological Activity of a Peptide Derived from a Major Histocompatibility Complex Class I Antigen

Jan Stagsted

Proceedings of The National Academy of Sciences, 1993

View PDFchevron_right

Determination of glutamic acid decarboxylase 65 peptides presented by the type I diabetes-associated HLA-DQ8 class II molecule identifies an immunogenic peptide motif

Janelle Noble

The Journal of Immunology, 2000

View PDFchevron_right

The motif for peptide binding to the insulin-dependent diabetes mellitus-associated class II MHC molecule I-Ag7 validated by phage display library

Luciano Adorini

International Immunology, 2000

View PDFchevron_right

The peptide binding specificity of the MHC class II I-A molecule of the Lewis rat, RT1.B 1

Miriam Eisenstein

International Immunology, 1996

View PDFchevron_right

The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding

Lawrence Stern

Structure, 1997

View PDFchevron_right

Exploration of the P6/P7 Region of the Peptide-binding Site of the Human Class II Major Histocompatability Complex Protein HLA-DR1

Lawrence Stern

Journal of Biological Chemistry, 2003

View PDFchevron_right

an Immunogenic Peptide Motif Identifies HLA-DQ8 Class II Molecule by the Type I Diabetes-Associated Decarboxylase 65 Peptides Presented Determination of Glutamic Acid

Andrew Cope

2000

View PDFchevron_right

A novel first primary anchor extends the MHC class II I-Ad binding motif to encompass nine amino acids

Kristian Bartnes

International Immunology, 1997

View PDFchevron_right

The importance of secondary anchor residue motifs of HLA class I proteins: A chemometric approach

Giulia Greco

Molecular Immunology, 1994

View PDFchevron_right

Peptide motif for the rat MHC class II molecule RT1. Da

Robert Weissert

View PDFchevron_right

Diabetes Diabetic Mice from Autoimmune E{alpha}Transgenic Nonobese MHC Class II Molecule That Protects A Peptide Binding Motif for I-Eg7, the

Giuseppe Penna

View PDFchevron_right

Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2)

Stefan Stevanovic

International Immunology, 1997

View PDFchevron_right

Autoimmune Diabetes-Transgenic Nonobese Diabetic Mice from α Class II Molecule That Protects E , the MHCg 7 A Peptide Binding Motif for I-E

Luciano Adorini

1999

View PDFchevron_right

Conformational and structural characteristics of peptides binding to HLA-DR molecules

Jonathan Rothbard

The Journal of Immunology

View PDFchevron_right

Molecular characterization of the diabetes-associated mouse MHC class II protein, I-Ag7

Felix Mor

International Immunology, 1997

View PDFchevron_right

The peptide-binding strategy of the MHC class II I-A molecules (original) (raw)

Related papers